Strides Pharma Science Limited: directors' dealings · India · SEBI (PIT + SAST) SEBI:strides-pharma-science-limited IN IN · SEBI (PIT + SAST) Mcap 61.7Bn€
Explore the full directors' dealings record of Strides Pharma Science Limited, a listed equity based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €61.7bn. The latest transaction was filed on 24 March 2022 (Purchase). Among the most active insiders: Pronomz Ventures LLP. The full history is free.
Financial data FY ended March 2025 · cache
Income statement
Revenue 43.92 Bn€
Gross profit 22.58 Bn€ 51% margin
Net income 35.93 Bn€ 81.8% margin
Balance sheet & cash
Market cap 61.68 Bn€
Total debt 18.80 Bn€
Free Cash Flow 4.42 Bn€
Last declaration on 24 March 2022
Declarations 39 total
Executives ● Purchase0 SEBI
€189,335 45,450 shares @ €4.1658
Equity Shares
SEBI:7b44e46e6ee249555dcb3809f062f27209ef52b0 · 21 Mar 2022
Ideal exit: 16 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€209,706 53,200 shares @ €3.9418
Equity Shares
SEBI:6c93527891d2065eb9a74c359c908a92c9ff60fa · 16 Mar 2022
Ideal exit: 11 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€1m 300,000 shares @ €3.8704
Equity Shares
SEBI:69c86e43d509cb7ad07af91fa9ff3f831b7d1cc8 · 14 Mar 2022
Ideal exit: 9 Dec 2022 (T+270) Executives ● Purchase0 SEBI
€1m 291,250 shares @ €3.8123
Equity Shares
SEBI:286771d5076760fe149bb2111c0338152f22f1eb · 4 Mar 2022
Ideal exit: 29 Nov 2022 (T+270) Executives ● Purchase0 SEBI
€194,096 52,000 shares @ €3.7326
Equity Shares
SEBI:0af2be3627c09e7fa760032f7f9ebe920aca4bf3 · 28 Feb 2022
Ideal exit: 25 Nov 2022 (T+270) Executives ● Purchase0 SEBI
€6,006 1,550 shares @ €3.875
Equity Shares
SEBI:bc3c6e68d87cb728c3dc5735166c79e88641781d · 24 Feb 2022
Ideal exit: 21 Nov 2022 (T+270) Executives ● Purchase0 SEBI
€590,897 155,200 shares @ €3.8073
Equity Shares
SEBI:886558ffe2f68a95a80a67b294fae2d78d3a58ad · 24 Feb 2022
Ideal exit: 21 Nov 2022 (T+270) Executives ● Sale0 SEBI
€19,049 2,600 shares @ €7.3265
Equity Shares
SEBI:da4da765acbf12a1efc02a7bcbec8077fe37f9e2 · 10 Aug 2021
Executives ● Sale0 SEBI
€29,106 4,000 shares @ €7.2764
Equity Shares
SEBI:bb89d6aeb99a1b397593d54f772b4b40a519282f · 22 Sept 2021
Executives ● Sale0 SEBI
€17,416 2,500 shares @ €6.9662
Equity Shares
SEBI:d336305a1693c2b445e9a62f1997ae6e7478c30e · 20 Sept 2021
Executives ● Purchase0 SEBI
€13,723 4,000 shares @ €3.4308
Equity Shares
SEBI:41a366a4c8db04da99e25821bfdf6d7a7c2a2bea · 6 Aug 2021
Ideal exit: 3 May 2022 (T+270) Executives ● Purchase11 SEBI
€12,998 3,750 shares @ €3.466 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:e8d76ac4b9005e038030bd8ecc4c171196962632 · 6 Sept 2021
Ideal exit: 3 Jun 2022 (T+270) Executives ● Purchase7 SEBI
€12,998 3,750 shares @ €3.466 0.0000% mcap 39.7% of flow
Equity Shares
SEBI:4f308a55bcecd1ca822cd6ad07991f38855c0941 · 6 Sept 2021
Ideal exit: 3 Jun 2022 (T+270) Executives ● Purchase6 SEBI
€12,998 3,750 shares @ €3.466 0.0000% mcap 28.8% of flow
Equity Shares
SEBI:43a75685095cb6fe8f5dc243b3c1243dacf97450 · 6 Sept 2021
Ideal exit: 3 Jun 2022 (T+270) Executives ● Purchase11 SEBI
€12,998 3,750 shares @ €3.466 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:1478c8e242cf09836975e6560cf2d406f5026753 · 6 Sept 2021
Ideal exit: 3 Jun 2022 (T+270) Executives ● Purchase11 SEBI
€13,864 4,000 shares @ €3.466 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:05255a66d070fc71fce0544ea378e9c1ee91e8b4 · 6 Sept 2021
Ideal exit: 3 Jun 2022 (T+270) Executives ● Sale11 SEBI
€160,619 20,000 shares @ €8.031 0.0003% mcap 100.0% of flow
Equity Shares
SEBI:36d17328b8f0f6e50fe1f3a41bd8c1310388bb52 · 10 Aug 2021
Executives ● Sale11 SEBI
€21,411 2,500 shares @ €8.5643 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:449285e23e3f0b296482651a7b09c85585bbf6e7 · 30 Jun 2021
Executives ● Sale10 SEBI
€32,177 3,750 shares @ €8.5806 0.0001% mcap 71.2% of flow
Equity Shares
SEBI:c44a5a569cc57282acbe3344cbfadbeb8b3ef8ba · 30 Jun 2021
Executives ● Purchase8 SEBI
€61,114 20,000 shares @ €3.0557 0.0001% mcap 49.8% of flow
Equity Shares
SEBI:8a4f4b71affa6d0c9a21cfeb56e0d360739d7fa8 · 30 Jun 2021
Ideal exit: 27 Mar 2022 (T+270) Executives ● Sale9 SEBI
€19,744 2,280 shares @ €8.6595 0.0000% mcap 60.3% of flow
Equity Shares
SEBI:12bfeb5a913c22334278a88627fcd141a41ec583 · 29 Jun 2021
Executives ● Purchase11 SEBI
€16,077 3,750 shares @ €4.2873 0.0000% mcap 100.0% of flow
Equity Shares
SEBI:5332f868d4313d6d68d867427d27e7fbf28f4cc0 · 30 Jun 2021
Ideal exit: 27 Mar 2022 (T+270) Executives ● Purchase3 SEBI
057,869 shares
Equity Shares
SEBI:626d1ecea5c5e7ca5c5ec4be6c7b466347d0e70e · 24 Jun 2021
Ideal exit: 21 Mar 2022 (T+270) Executives ● Sale3 SEBI
088,734 shares
Equity Shares
SEBI:e2bf6e4ac4065df6c1c8fc0b1f112f91019d1ec6 · 24 Jun 2021
Executives ● Sale3 SEBI
061,122 shares
Equity Shares
SEBI:888cd758f80a6a6a0c29777f4e18472d50e71df5 · 24 Jun 2021
25 of 39 declarations
Load more (14 remaining)